Solvay Articles
Solvay costs and Meridia withdrawal take heavy toll on Abbott Labs 3rd-qtr 2010 results
21 October 2010
Abbott Labs plans cost-cutting, 3,000 job losses as a result of Solvay integration
22 September 2010
Abbott Labs gives up on vaccines unit sale, as no adequate bidders in sight; heart risks reported with obesity drug Meridia
6 September 2010
Abbott Labs to sell flu vaccine business acquired with Solvay? Hospira buy of Javelin to complete
30 June 2010
Belgium’s UCB posts disappointing 2009 results, but projects better future based on newer drugs
3 March 2010
Neuropathic pain - brighter future for pipeline drugs with market to double in value to $5.2 billion
17 February 2010
Abbott Labs completes its $6.2 billion acquisition of Solvay Pharma
16 February 2010
EU Commission clears planned acquisition of Solvay Pharma by Abbott, subject to divestiture of cystic fibrosis interests
12 February 2010
Burst of M&A activity in pharma during 2009 led by mega-deals from Pfizer/Wyeth and Merck & Co/S-P
4 February 2010
Pharmaceutical M&A deals in 2009
4 February 2010
Belgium’s UCB to maximize US focus and resources on core products, hiving off primary care to Sanofi and Teva
1 February 2010
Abbott Lab’s 4th-quarter 2009 profit flat due to charges, buts sales rise nearly 11% driven by Humira; still open to buys
28 January 2010
EU Commission delays decision on Abbott’s acquisition of Solvay; clears Archimedes takeover
25 January 2010
Sharp rise in US FDA approvals of biopharmaceuticals in 2009, highest since 2005, says BII
18 January 2010
Watson buy of Arrow requires product divestments, says USA’s FTC
4 December 2009
Abbott to buy Solvay pharmaceuticals business for 4.5 billion euros, but will bidding war cease?
28 September 2009
Solvay Pharma unit set to see a bidding war
24 September 2009
Nycomed seeks new cash for Solvay buyout –sources?
10 August 2009
Abbott and AZ set to co-promote TriLipix
5 June 2009
Solvay licenses HUYA's CV drugs
21 May 2009
Profit plummets 55% for Solvay in recession
15 May 2009
EVM meets EC and EMEA over swine flu
30 April 2009
Stock Commentary - Europe - week to April 20, 2009
23 April 2009
Stock Commentary - Europe - week to April 13, 2009
16 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
Solvay viewing options for pharma
2 April 2009
17% jump in 2008 profit for Stallergenes
27 March 2009
Major US federal switch on medicinal marijuana
23 March 2009
Stock Commentary - Europe - week to mar 2, 2009
9 March 2009
Fenofibrate cuts CV risk 27% in some patients
9 March 2009
Stock Commentary - Europe - week to Feb 23, 2009
2 March 2009
Lexapro and Zoloft are "best" antidepressants
9 February 2009
US Court dismisses whistleblower case against drugmaker
19 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Recipharm takes over AZ Swedish bio facility
12 January 2009
Wyeth buys UK biotech Thiakis for $150M
12 January 2009
FDA approves Abbott's cholesterol drug
22 December 2008
Intercell gets $12.5M HHS funding for flu vacc patch system
22 December 2008
Solvay discontinues CB1 obesity drug SLV319
24 November 2008
Stock Commentary - Europe - week to Nov 17, 2008
24 November 2008
Solvay launches R3i non-profit organization
17 November 2008
Solvay's 9-month profit down 34% on Fortis
10 November 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
York Pharma buys brands from Solvay
13 October 2008
Stock Commentary - Europe - week to Sept 22, 2008
29 September 2008
Solvay debuts web site on low testosterone awareness
1 September 2008
York Pharma raises L3.9 million
11 August 2008
Solvay's first-half 2008 profit declines 15%
11 August 2008
Stock Commentary - Europe - week to July 21, 2008
28 July 2008
Gen-Probe will not raise Innogenetics bid
14 July 2008
ArQule's 1st-qtr loss narrows to $13.9M
26 May 2008
Solvay's 1st-qtr 2008 net income rises 1%
26 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
Stock Commentary - Europe - week to May 5, 2008
12 May 2008
Abbott's TriLipix improves key lipid measures
7 April 2008
Zetia "could be expensive placebo," ACC hears
7 April 2008
Abbott gets $100M under Simcor deal
24 March 2008
Stock Commentary - Europe - week to March 3, 2008
10 March 2008
Wyeth and Solvay end bifeprunox accord
10 March 2008
Fournier challenges Teva's US generic TriCor
10 March 2008
FDA approves Luvox ER for anxiety and OCD
10 March 2008
Pharma seen as good employer, survey finds
25 February 2008
Stock Commentary - Europe - week to Feb 18, 2008
25 February 2008
Solvay's 2007 income climbs just 1%
25 February 2008
California OKs medical marijuana dispensers
14 February 2008
Jazz' Luvox PDUFA set for Feb 29
11 February 2008
Teva files ANDA for Fournier/Solvay's fenofibrate
4 February 2008
Stock Commentary - Europe - week to Jan 7, 2008
14 January 2008
DNage and Solvay join TI group on brain disease
24 December 2007
FDA c'ttee says "no" to tedisamil approval
24 December 2007
Solvay sells French site of Fournier
10 December 2007
Solvay
19 November 2007
Solvay negotiating sale of Fournier's Synkem
19 November 2007
Solvay's 3rd-qtr 2007 net income jumps 25%
5 November 2007
Solvay to co-promote Abbott's Simcor in USA
29 October 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
